The Bid & Ask

Quotations, Dispatches, and the Daily Tape

Friday, August 14, 2026

Subject of the day

ELAN

Concerning the House

Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals worldwide. The company offers pet health products, such as parasiticides, vaccines, and therapeutics that protect pets from fleas, ticks, and internal parasites under the Seresto, K-9 Advantage, Advantix, and Advocate trademarks; prescription parasiticide products, an over-the-counter treatments for the prevention and elimination of fleas and ticks under the Credelio Family, Interceptor Plus, Drontal family, and Drontal Plus; vaccines portfolio that provides differentiated prevention coverage for a number of important pet health risks; and therapeutics portfolio for the treatment of pain, otitis, cardiovascular, and dermatology indications, as well as osteoarthritis for dogs and cats under the Galliprant trademark. It also provides farm animal products that help farmers improve animal health and wellbeing, and raise livestock, such as cattle, swine, and poultry. In addition, the company offers medicated feed additives, injectable antibiotics, vaccines, insecticides and enzymes, and others under the Rumensin, Baytril, and Experior trademarks for cattle; and under the Maxiban and Monteban trademarks for the control and prevention of intestinal disease in poultry. Further, it offers other pet health products for cats and dogs under the Atopica, Milbemax, Onsior, and Tru Family trademarks; and other farm animal products for poultry, cattle, and swine under the AviPro, Catosal, Denagard, Hemicell, Pulmotil, and Surmax tradmarks. The company sells its products to third-party distributors and independent retailers; and directly to farm animal producers and veterinarians. Elanco Animal Health Incorporated was founded in 1954 and is headquartered in Indianapolis, Indiana.

United States · www.elanco.com

The Long Run

FY 2018–2025 · 8 years

LineLatestCAGRTrend
Revenue$4.42B+6.3%
Net income$338.00M+97.7%
Cash from ops$271.00M-8.0%
Quotation

$22.51

+0.38 (+1.7%)

52w hi$26.84
52w lo$17.35
Vol3.29M
As ofAug 13
The Verdict

Hold

Our score +0.06

Short-0.08
Medium+0.17
Long+0.12

computed 2026-08-13

By the Numbers

Elanco Animal Health Incorporated

Healthcare · Drug Manufacturers - Specialty & Generic

Market cap$11.25B
Enterprise value$14.76B
Trailing P/E
Forward P/E17.81x
EV / EBITDA14.66x
P / S (ttm)2.24x
Profit margin-4.0%
Return on equity-3.0%
Revenue growth+10.2%
Earnings growth+440.5%
Debt / equity64.25
Risk Metrics
Beta vs SPX1.33
Corr SPX0.46
Annual vol47.5%
Annual ret+40.9%
Sharpe0.86
Max DD-47.6%

Window: 504 trading days (504 obs)

Layer Breakdown
LayerRawContribution
Fundamental+0.16
Sector+0.12
Technical+0.00
Earnings+0.00
Sentiment+0.00

macro × 1.00 · 2026-08-13

Recent Sessions
DateOpenHighLowCloseVol
Aug 13$22.31$22.68$22.17$22.513.29M
Aug 12$22.40$22.50$21.75$22.139.72M
Aug 11$23.00$23.07$22.557.55M
Aug 10$22.12$22.81$21.32$22.2822.49M
Aug 7$24.38$24.41$22.02$22.1222.08M